Maxwell, Patrick H.
Eckardt, Kai-Uwe
Article History
First Online: 14 December 2015
Competing interests
: P.H.M. is the scientific founder, a shareholder and director of ReOx. K.-U.E. has received consultancy fees from companies that produce or distribute therapeutics for management of anaemia, including Akebia, Amgen, AstraZeneca, Johnson & Johnson, Roche, Sandoz, Takeda and Vifor. He has also received grant support from Amgen and Bayer for the German Chronic Kidney Disease (GCKD) study.